
0000939798-16-000137
<SEC-DOCUMENT>0000939798-16-000137.txt : 20160811
<SEC-HEADER>0000939798-16-000137.hdr.sgml : 20160811
<ACCEPTANCE-DATETIME>20160811104212
ACCESSION NUMBER:
CONFORMED SUBMISSION TYPE:
PUBLIC DOCUMENT COUNT:
CONFORMED PERIOD OF REPORT:
Entry into a Material Definitive Agreement
ITEM INFORMATION:
ITEM INFORMATION:
Departure of Directors or Certain Officers; Election of 
Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain
Officers
ITEM INFORMATION:
FILED AS OF DATE:
DATE AS OF CHANGE:
Other Events
20160811
8-K
1
20160809
20160811
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME:
CENTRAL INDEX KEY:
STANDARD INDUSTRIAL CLASSIFICATION: CRUDE PETROLEUM & NATURAL GAS
Growblox Sciences, Inc.
0001165320
[1311]
IRS NUMBER:
STATE OF INCORPORATION:
FISCAL YEAR END:
593733133
DE
0831
FILING VALUES:
FORM TYPE:
SEC ACT:
SEC FILE NUMBER: 000-55462
FILM NUMBER:
8-K
1934 Act
161823359
BUSINESS ADDRESS:
STREET 1:
CITY:
STATE:
ZIP:
BUSINESS PHONE:
6450 CAMERON STREET #110A
LAS VEGAS
NV
89118
(844) 843-2569
MAIL ADDRESS:
STREET 1:
CITY:
STATE:
ZIP:
FORMER COMPANY:
6450 CAMERON STREET #110A
LAS VEGAS
NV
89118
FORMER CONFORMED NAME: Signature Exploration & Production Corp.
DATE OF NAME CHANGE:
20080602
FORMER COMPANY:
FORMER CONFORMED NAME: Diabetic Treatment Centers of America, Inc.
DATE OF NAME CHANGE:
20040812
FORMER COMPANY:
FORMER CONFORMED NAME: FLAGSTICK VENTURES INC
DATE OF NAME CHANGE:
20020117
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>gblxeightk.htm
<DESCRIPTION>GBLX 8-K AUG 11, 2016
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: Gary R. Henrie, Attorney at Law
    Document created using EDGARfilings PROfile 4.0.0.0
    Copyright 1995 - 2016 Summit Financial Printing, LLC.  All rights 
reserved.-->
</head>
<body style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" 
bgcolor="#ffffff" text="#000000">
<div>
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">UNITED STATES</div>
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">SECURITIES AND EXCHANGE COMMISSION</div>
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Washington, D. C. 20549</div>
<div><br>
</div>
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">FORM 8-K</div>
<div><br>
</div>
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">CURRENT REPORT</div>
<div><br>
</div>
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Pursuant to Section 13 Or 15(d) of the</div>
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Securities Exchange Act of 1934</div>
<div><br>
</div>
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt">Date of Report (Date of earliest event reported): August 9, 
2016</div>
<div><br>
</div>
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><u>Growblox Sciences, Inc.</u></div>
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt">(Exact name of Registrant as specified in its charter)</div>
<div><br>
</div>
<div><br>
</div>
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
SIZE: 10pt" id="8a66dab28f82486a9a823cb8cae2d2c0" cellspacing="0"
cellpadding="0">
<tr>
<td style="BORDER-BOTTOM: black 2px solid; WIDTH: 33.33%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Delaware</div>
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt">(State or other Jurisdiction of<font style="FONT-FAMILY: 'Times
New Roman', Times, serif; FONT-SIZE: 10pt"><br>
</font> Incorporation or organization)</div>
</td>
<td style="BORDER-BOTTOM: black 2px solid; WIDTH: 33.33%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">000-55462</div>
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt">(Commission File Number)</div>
</td>
<td style="BORDER-BOTTOM: black 2px solid; WIDTH: 33.33%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">59-3733133</div>
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt">(IRS Employer I.D. No.)</div>
</td>
</tr>
</table>
<div><br>
</div>
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">3550 W. Teco Avenue</div>
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Las Vegas, Nevada 89118</div>
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Phone: (844) 843-2569</div>
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt">(Address, including zip code, and telephone number, including 
area code, of</div>
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt">registrant's principal executive offices)</div>
<div><br>
</div>
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold"><u>N/A</u></div>
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt">(Former name, former address and former fiscal year, if changed
since last report)</div>
<div><br>
</div>
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt">Check the appropriate box below if the Form 8-K filing is 
intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</div>
<div style="TEXT-ALIGN: left"><br>
</div>
<div style="TEXT-ALIGN: left"><font style="FONT-FAMILY: 'Segoe UI Symbol', sans-
serif; FONT-SIZE: 10pt">&#9744;</font><font style="WIDTH: 36pt; DISPLAY: inline-
block; FONT-SIZE: 1px" id="TRGRRTFtoHTMLTab">&#160;</font><font style="FONT-
FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div>
<div style="TEXT-ALIGN: left"><br>
</div>
<div style="TEXT-ALIGN: left"><font style="FONT-FAMILY: 'Segoe UI Symbol', sans-
serif; FONT-SIZE: 10pt">&#9744;</font><font style="WIDTH: 36pt; DISPLAY: inline-
block; FONT-SIZE: 1px" id="TRGRRTFtoHTMLTab">&#160;</font><font style="FONT-
FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Soliciting material 
pursuant to Rule l 4a- l 2 under the Exchange Act ( 17 CFR 240. l 4a- l 
2)</font></div>
<div style="TEXT-ALIGN: left"><br>
</div>
<div style="TEXT-ALIGN: left"><font style="FONT-FAMILY: 'Segoe UI Symbol', sans-
serif; FONT-SIZE: 10pt">&#9744;</font><font style="WIDTH: 36pt; DISPLAY: inline-
block; FONT-SIZE: 1px" id="TRGRRTFtoHTMLTab">&#160;</font><font style="FONT-
FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Pre-commencement 
communications pursuant to Rule l 4d-2(b) under the Exchange Act (17 CFR 240. l 
4d-2(b))</font></div>
<div style="TEXT-ALIGN: left"><br>
</div>
<div style="TEXT-ALIGN: left"><font style="FONT-FAMILY: 'Segoe UI Symbol', sans-
serif; FONT-SIZE: 10pt">&#9744;</font><font style="WIDTH: 36pt; DISPLAY: inline-
block; FONT-SIZE: 1px" id="TRGRRTFtoHTMLTab">&#160;</font><font style="FONT-
FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Pre-commencement 
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240. l 
3e-4(c))</font></div>
<div><br>
</div>
<div><br>
</div>
<div style="BACKGROUND-COLOR: #ffffff">
<div><br>
</div>
<div style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both" 
id="DSPFPageBreakArea">
<div style="TEXT-ALIGN: center" id="DSPFPageNumberArea"><font style="FONT-STYLE:
normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 8pt; FONT-
WEIGHT: normal" id="DSPFPageNumber">1</font></div>
<div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; 
WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; 
COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade="noshade">
</div>
</div>
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman', Times, serif;
FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 1.01 Entry into a Material Definitive 
Agreement.</div>
<div><br>
</div>
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt">On August 4, 2016, the Company entered into the Second Omnibus 
Amendment ("Amendment") of its existing agreements with Pacific Leaf Ventures, 
LP ("Pacific Leaf").&#160; The Amendment eliminates Pacific Leaf's option to 
purchase up to a 20% membership interest in GB Sciences Nevada LLC, a wholly 
owned subsidiary of the Company ("GBS") and reduces Pacific Leaf's existing 
royalty rate to 16.4% of the gross sales revenue of GBS.&#160; It also caps 
maximum aggregate royalty payments to be made to Pacific Leaf at $2,420,000 with
respect to any calendar year. In consideration of the amended terms, Pacific 
Leaf will receive 1,000,000 shares of the Company's common stock and a five-year
warrant to purchase 1,500,000 shares of the Company's common stock at $0.36 per 
share.</div>
<div><br>
</div>
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt">On August 9, 2016, the Company finalized a settlement agreement
in final disposition of the lawsuit filed by the Company on April 2, 2014, in 
the United States District Court for the Southern District of New York.&#160; 
The suit is more particularly described in Part I, Item 3 of the Company's 
Annual Report on Form 10-K filed by the Company with the Securities and Exchange
Commission on July 14, 2016.&#160; The Company's obligation under the agreement 
is to issue 1,400,000 shares of restricted common stock to certain non-
affiliates of the Company.</div>
<div style="TEXT-ALIGN: left"><br>
</div>
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 5.02 Departure of Directors or Certain 
Officers; Election of Directors; Appointment of Certain Officers; Compensatory 
Arrangements of Certain Officers.</div>
<div><br>
</div>
</div>
<div style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; FONT-FAMILY: 'Times New
Roman', Times, serif; MARGIN-BOTTOM: 10pt; FONT-SIZE: 10pt">On August 5, 2016, 
the Company's Board of Directors accepted the resignation of John Poss as Chief 
Financial Officer of the Company and appointed Ksenia Griswold as the Company's 
Vice President and Chief Financial Officer. Mr. Poss will continue to serve as 
the President, Chief Executive Officer, and Chief Operating Officer of the 
Company. Ms. Griswold has been serving as the controller of the Company since 
November, 2015.&#160; For the five years prior to that time beginning in 
October, 2010, she worked in the Las Vegas, Nevada office of Ernst &amp; Young, 
LLP.&#160; At the time of her departure from Ernst &amp; Young, she was audit 
manager.&#160; It is expected that an amendment to Ms. Griswold's employment 
agreement and compensation will be negotiated during the upcoming fiscal 
quarter.</div>
<div style="BACKGROUND-COLOR: #ffffff">
<div style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; FONT-FAMILY: 'Times New
Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 8.01 Other 
Events</div>
<div><br>
</div>
<div style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; FONT-FAMILY: 'Times New
Roman', Times, serif; FONT-SIZE: 10pt">The Company recently completed a 
$3,000,000 private placement of its common stock.</div>
<div><br>
</div>
<div style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both" 
id="DSPFPageBreakArea">
<div style="TEXT-ALIGN: center" id="DSPFPageNumberArea"><font style="FONT-STYLE:
normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 8pt; FONT-
WEIGHT: normal" id="DSPFPageNumber">2</font></div>
<div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; 
WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; 
COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade="noshade">
</div>
</div>
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt">&#160;</div>
</div>
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">SIGNATURE PAGE</div>
<div><br>
</div>
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt">Pursuant to the requirement of the Securities and Exchange Act 
of 1934, the Registrant has duly caused this report to be signed on its behalf 
by the undersigned hereunto duly authorized.</div>
<div><br>
</div>
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-
SIZE: 10pt" id="53a2fb94256a466f8f4b2c1f6620cfbc" cellspacing="0" 
cellpadding="0">
<tr>
<td style="WIDTH: 51.89%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 42.2%; VERTICAL-ALIGN: top" colspan="3">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt; FONT-WEIGHT: bold">Growblox Sciences, Inc.</div>
</td>
<td style="WIDTH: 5.91%; VERTICAL-ALIGN: top">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 51.89%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 3.9%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 3.4%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 34.9%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.91%; VERTICAL-ALIGN: top">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 51.89%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt">Dated: August 10, 2016</div>
</td>
<td style="WIDTH: 3.9%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 3.4%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman', Times, serif; 
FONT-SIZE: 10pt">By:</div>
</td>
<td style="BORDER-BOTTOM: #000000 2px solid; WIDTH: 34.9%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman', Times, serif; 
MARGIN-LEFT: 27pt; FONT-SIZE: 10pt">/s/ John Poss</div>
</td>
<td style="WIDTH: 5.91%; VERTICAL-ALIGN: top">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 51.89%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 3.9%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 3.4%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 34.9%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman', Times, serif; 
MARGIN-LEFT: 18pt; FONT-SIZE: 10pt">John Poss</div>
</td>
<td style="WIDTH: 5.91%; VERTICAL-ALIGN: top">&#160;</td>
</tr>
<tr>
<td style="WIDTH: 51.89%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 3.9%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 3.4%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 34.9%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman', Times, serif; 
MARGIN-LEFT: 18pt; FONT-SIZE: 10pt">Chief Executive Officer</div>
</td>
<td style="WIDTH: 5.91%; VERTICAL-ALIGN: middle">&#160;</td>
</tr>
</table>
<div style="MARGIN-BOTTOM: 10pt"><br>
</div>
<div style="MARGIN-BOTTOM: 10pt"><br>
</div>
<div style="MARGIN-BOTTOM: 10pt"><br>
</div>
</div>
<div style="TEXT-ALIGN: center" id="DSPFPageNumberArea"><font style="FONT-STYLE:
normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 8pt; FONT-
WEIGHT: normal" id="DSPFPageNumber">3</font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>